News | July 24, 2022
WuXi AppTec plans to build a new site in Singapore
Better serving global partners and advancing healthcare innovation
Better serving global partners and advancing healthcare innovation
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
This biopharmaceutical facility is one most significant private sector investment ever in the Middletown region
WuXi STA opens a new large scale continuous manufacturing plant
Site Enhances New Modality CRDMO Platform Capacity for Customers
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)